NDA submission for Starpharma’s VivaGel BV
Drug Discovery | News | 0 Comment | 21 Nov, 2017
Singapore - Australian biotech company Starpharma submitted its New Drug Application (NDA) with the US FDA through a rol...Read more
Mitsubhishi Tanabe Pharma's ALS drug treats more than 1000 people in three months
Drug Discovery | News | 2 Comment | 17 Nov, 2017
Japan’s Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic latera...Read more
Drug Discovery | News | 0 Comment | 15 Nov, 2017
Seres Therapeutics, The University of Texas MD Anderson Cancer Center (MD Anderson), and the Parker Institute ...Read more
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies
Drug Discovery | News | 0 Comment | 15 Nov, 2017
Life Science company Bayer has entered into an exclusive global collaboration with US based biopharma company Loxo Oncol...Read more
Korea's Dongsung Pharmaceuticals opens a new cancer research center in Seoul
Drug Discovery | News | 0 Comment | 14 Nov, 2017
In a bid to further strengthen its pipeline of cancer treatments, Korea’s Dongsung Pharmaceuticals has recently op...Read more
Helperby Therapeutics develops sustainable solution for antibiotic resistance
Drug Discovery | News | 0 Comment | 13 Nov, 2017
UK based pharma company, Helperby Therapeutics has developed Antibiotic Resistance Breakers (ARBs) as a solution to the ...Read more
Amgen And Novartis announce expanded collaboration with Banner Alzheimer's Institute
Drug Discovery | News | 0 Comment | 03 Nov, 2017
Singapore – Amgen and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to ...Read more
Boehringer Ingelheim and Dicerna collaborate to develop treatments for chronic liver diseases
Drug Discovery | News | 0 Comment | 02 Nov, 2017
Pharma company Boehringer Ingelheim and leading developer of RNAi therapeutics Dicerna Pharmaceuticals has announced a r...Read more
Evolution of drug delivery system for better patient safety
Drug Discovery | News | 0 Comment | 01 Nov, 2017
Chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis are on the rise and often require daily...Read more
CFDA accepts Eisai's NDA for cancer drug
Drug Discovery | News | 0 Comment | 31 Oct, 2017
Eisai Co., Ltd. announced that the China Food and Drug Administration (CFDA) has accepted for review a New Drug Ap...Read more
New 'Double Decker' Antibody Technology Fights Cancer
Drug Discovery | News | 0 Comment | 26 Oct, 2017
Singapore - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created...Read more
Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine
Drug Discovery | News | 0 Comment | 26 Oct, 2017
Singapore - Alopexx Vaccine LLC (a US- based science driven investment company) announced that it has completed a Phase ...Read more
Incyte and MacroGenics collaborates for anti-PD-1 monoclonal antibody
Drug Discovery | News | 0 Comment | 26 Oct, 2017
Biopharma company, Incyte Corporation and MacroGenics has announced that the companies have entered into an exclusi...Read more
AbbVie plows $205M upfront Into Alector's Alzheimer's Program
Drug Discovery | News | 0 Comment | 25 Oct, 2017
AbbVie announced a strategic collaboration with South San Francisco-based Alector to develop and commercialize drugs for...Read more
Eisai, Biogen expand their agreement to codevelop and commercialize AD drug
Drug Discovery | News | 0 Comment | 24 Oct, 2017
Japan’s Eisai and US based Biogen announced the expansion of their existing collaboration agreement ...Read more
Drug Discovery | Opinion | 2 Comment | 13 Oct, 2017
Q. Can you briefly explain this new blood testing technology and how is it different from the more conventional tests th...Read more
Novel bi-specific antibody shows strong therapeutic potential to treat Zika virus infection
Drug Discovery | News | 0 Comment | 12 Oct, 2017
Singapore - The Journal Cell published data with a bi-specific antibody against Zika virus infection. The article is ent...Read more
Drug Discovery | News | 0 Comment | 10 Oct, 2017
Singapore – Johnson & Johnson (J&J) announced the launch of its three-monthly long-acting treatment for sc...Read more